Stride Shasun receives USFDA approval for constipation treatment

Strides ShasunPharma company Strides Shasun announced that it received the United States Food & Drug Administration (USFDA) approval for Polyethylene Glycol powder to treat occasional constipation.

The powder when consumed as a solution works by softening the stool and increasing the frequency of bowel movement by retaining water in the stool, added the company.

Yeterday the company had received approval for generic Ranitidine Tablets, used to treat and prevent ulcers in the stomach and intestines from the US FDA.

Strides Shasun is a vertically integrated global pharmaceutical Company head quartered in Bangalore. The Company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.

The Company has 14 manufacturing facilities across three continents and commercial reach to 85 countries.